Strand Therapeutics

strandtx.com

Strand Therapeutics is an early-stage biotechnology company that is pioneering the development of programmable, long-acting mRNA therapeutics. Utilizing a proprietary platform that combines synthetic biology, engineering, and chemistry, Strand is focused on creating autonomous medicines that can deliver precise, multi-functional, potentially curative treatments. Their innovative approach involves programming logic-based circuits into mRNA, allowing it to sense different cell types and activate only in diseased cells, thereby enhancing the therapeutic window. With a pipeline aimed at improving treatment options for cancer and other life-threatening diseases, Strand is positioned at the forefront of the mRNA therapeutics market, backed by a team of world-leading researchers from the MIT Synthetic Biology Center.